Giron L T, McCann S A, Crist-Orlando S G
Eur J Pharmacol. 1985 Sep 24;115(2-3):285-90. doi: 10.1016/0014-2999(85)90701-0.
In order better to interpret their physiological role in rat spinal cord, we characterized binding sites of [3H]WB-4101 and [3H]p-aminoclonidine ( [3H] PAC), and determined their regional distribution. These binding sites have characteristics required for, respectively, alpha 1 and alpha 2 receptors of norepinephrine. Binding to these sites is saturable, with Kd values of 0.38 nM and 35 nM for high and low affinity binding sites respectively of [3H]WB-4101; and 1.7 nM, for a single binding site of [3H]PAC. For whole cord, Bmax values are 52 and 320 (high and low affinity sites respectively); and 21 fmol/mg protein. Catecholamines compete stereoselectively for these sites, while selected noradrenergic agents compete with an order of potency corresponding to their relative activity at the alpha 1 and alpha 2 receptors. We conclude that spinal alpha 1 and alpha 2 binding sites have the same pharmacologic properties as corresponding peripheral sites. The alpha 2 and, to a lesser degree, the alpha 1 binding sites vary in concentration with region. Our results support the contention that alpha 2 binding sites subserve neuronal function in the spinal cord.
为了更好地阐释它们在大鼠脊髓中的生理作用,我们对[3H]WB - 4101和[3H]对氨基可乐定([3H]PAC)的结合位点进行了表征,并确定了它们的区域分布。这些结合位点分别具有去甲肾上腺素α1和α2受体所需的特性。与这些位点的结合是可饱和的,[3H]WB - 4101的高亲和力和低亲和力结合位点的Kd值分别为0.38 nM和35 nM;[3H]PAC的单一结合位点的Kd值为1.7 nM。对于整个脊髓,Bmax值分别为52和320(分别为高亲和力和低亲和力位点);以及21 fmol/mg蛋白质。儿茶酚胺对这些位点具有立体选择性竞争,而选定的去甲肾上腺素能药物以与其在α1和α2受体上的相对活性相对应的效力顺序进行竞争。我们得出结论,脊髓α1和α2结合位点具有与相应外周位点相同的药理特性。α2结合位点以及在较小程度上α1结合位点的浓度随区域而变化。我们的结果支持α2结合位点在脊髓中发挥神经元功能的观点。